BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Kerastem Reports Successful U.S. Phase II Hair Growth Clinical Trial Results

  The Kerastem therapy is a one-time treatment that utilizes adipose derived regenerative cells combined with purified fat delivered to the affected area of scalp.

  December 7, 2017

   · 

  2 min read
• Drug Development

  CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in β-thalassemia

  CTX001 is an investigational CRISPR gene-edited autologous hematopoietic stem cell therapy for patients suffering from β-thalassemia and sickle cell disease.

  December 7, 2017

   · 

  5 min read
• Orthocell Commences Treatment of its 1,000th Patient

  This marks a significant milestone in the Company’s history as it continues to clinically validate its market leading regenerative medicine technologies and drive entry into the US, the world’s largest healthcare market.

  December 7, 2017

   · 

  4 min read
• EOS Imaging Awarded ihe Prix Galien in ihe Medical Device Category

  EOS Imaging today announced the Galien Foundation has awarded it the Prix Galien in the Medical Device category.

  December 7, 2017

   · 

  2 min read